IP Library Granted Patent US 8,247,417
Granted Patent B2
US 8,247,417 · App. 13/271,825 · Granted Aug 21, 2012

Methods of treatment of chronic pain using eszopiclone

Assignee: Sunovion Pharmaceuticals Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,247,417
App. No.
13/271,825
Granted
Aug 21, 2012
Kind
B2
Abstract

The invention relates to the use of eszopiclone for the treatment of low-level, chronic pain and fatigue associated with pain.

Claims (4)

1. A method for treating neuropathic pain in a patient suffering from neuropathic pain, the method comprising administering to the patient a therapeutically effective amount of eszopiclone having an enantiomeric excess greater than 90%.

2. A method according to claim 1 , wherein the therapeutically effective amount of eszopiclone is administered parenterally, transdermally, orally or by inhalation.

3. A method according to claim 1 , wherein the therapeutically effective amount of eszopiclone is administered in an amount of 0.5 mg to 15 mg per day.

4. A method according to claim 3 , wherein the therapeutically effective amount of eszopiclone is administered in an amount chosen from 0.5 mg, 1.0 mg, 2.0 mg, and 3.0 mg per dosage.

Assignments (3)
SECURITY INTEREST Recorded Jan 6, 2023
From: WOODWARD SPECIALTY LLC
To: ALTER DOMUS (US) LLC
Reel/Frame 062301/0927 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2022
From: SUNOVION PHARMACEUTICALS INC.
To: WOODWARD SPECIALTY LLC
Reel/Frame 062068/0177 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2012
From: WESSEL, THOMAS; CARON, JUDY
To: SUNOVION PHARMACEUTICALS INC.
Reel/Frame 027512/0957 →
Continuity (4)
Continuation 12838554 · Jul 19, 2010
Continuation 11099078 · Apr 5, 2005
Provisional Application 60559590 · Apr 5, 2004
Related Publication 20120035182A1 · Feb 9, 2012